Microcurrent Therapy and Low-Level Laser Therapy on Wound Healing

April 6, 2022 updated by: Nehad Ahmed Youness Abo-zaid

Microcurrent Therapy Versus Low-Level Laser Therapy on Post-surgical Wound Healing

The study aiming to compare between the Microcurrent and Low-Level Laser Therapy on wound healing

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study designed to compare between the Microcurrent and Low-Level Laser Therapy on wound healing

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 50 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • patient recently undergo appendectomy

Exclusion Criteria:

  • patient with neurological disorders
  • patient with metabolic disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: medical therapy group
formed of 20 patients to whom ordinary medical therapy as the pervious groups and placebo shame laser had been applied.
Other: Medical therapy
Medical therapy
EXPERIMENTAL: medical therapy and Microcurrent group
formed of 20 patients to whom the microcurrent therapy had been applied with ordinary medical therapy.
Other: Medical therapy
Medical therapy
Device: Microcurrent therapy
Microcurrent therapy
EXPERIMENTAL: medical therapy and Low-Level Laser Therapy group
formed of 20 patients to whom the Low Level Laser Therapy had been applied with ordinary medical therapy.
Other: Medical therapy
Medical therapy
Device: Low Level Laser Therapy
Laser therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
levels of matrix metalloproteinases
Time Frame: assessed at day 3 post operative
analyze by Enzyme-linked immunosorbent assay
assessed at day 3 post operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
levels of matrix metalloproteinases
Time Frame: assessed at day 30 post operative
analyze by Enzyme-linked immunosorbent assay
assessed at day 30 post operative
the tissue inhibitors of metalloproteinases
Time Frame: assessed at day 3 post operative
analyze by Enzyme-linked immunosorbent assay
assessed at day 3 post operative
the tissue inhibitors of metalloproteinases
Time Frame: assessed at day 30 post operative
analyze by Enzyme-linked immunosorbent assay
assessed at day 30 post operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nehad Ahmed Youness Abo-zaid

Investigators

  • Principal Investigator: Nehad A. Abo-zaid, PHD, South Valley University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

April 28, 2022

Primary Completion (ANTICIPATED)

September 30, 2022

Study Completion (ANTICIPATED)

October 30, 2022

Study Registration Dates

First Submitted

March 23, 2022

First Submitted That Met QC Criteria

April 6, 2022

First Posted (ACTUAL)

April 13, 2022

Study Record Updates

Last Update Posted (ACTUAL)

April 13, 2022

Last Update Submitted That Met QC Criteria

April 6, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/002599

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wound Healing Delayed

Clinical Trials on Medical therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe